Analysis of 12 Months Clinical Outcomes Associated with Implantation of Ultrathin (60 μm) Bare Metal Stent in an Unselected Real-world Population with Coronary Artery Disease | Zendy

Adikesava Naidu Otikunta | Zendy; Uday Kumar Hosad | Zendy; Y.V. Subba Reddy | Zendy; E. Srikanth | Zendy; Ravi Srinivas | Zendy; Rajeev Garg | Zendy; Limmy Loret Lobo | Zendy

Open Access

Analysis of 12 Months Clinical Outcomes Associated with Implantation of Ultrathin (60 μm) Bare Metal Stent in an Unselected Real-world Population with Coronary Artery Disease

Author(s) -

Adikesava Naidu Otikunta,

Uday Kumar Hosad,

Y.V. Subba Reddy,

E. Srikanth,

Ravi Srinivas,

Rajeev Garg,

Limmy Loret Lobo

Publication year - 2017

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2017/24767.9896

Subject(s) - mace , medicine , restenosis , clinical endpoint , myocardial infarction , stent , coronary artery disease , bare metal stent , surgery , incidence (geometry) , population , cardiology , target lesion , drug eluting stent , clinical trial , percutaneous coronary intervention , physics , environmental health , optics

In the era of drug-eluting stents, Bare Metal Stent (BMS) has worked its way up to be recognized in several indications. Moreover, literature suggests that strut thickness has been directly related to the restenosis rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research